Answers are grounded in this paper and cite their sources.
NK-TCR cell therapy enhances NK cell efficacy against tumors through additional TCR-mediated lysis. Furthermore, the dual efficacy of NK-TCR permits the specific targeting of tumors and the associated TCR-associated immune resistance, making NK-TCR a unique cellular therapeutic.
No takes yet. Share an insight, caveat, or question.
Morton et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: